Anne M Remes Selected Research

Arg Transfer RNA

2/2016	Genetic aetiology of ophthalmological manifestations in children - a focus on mitochondrial disease-related symptoms.
8/2004	Molecular epidemiology of childhood mitochondrial encephalomyopathies in a Finnish population: sequence analysis of entire mtDNA of 17 children reveals heteroplasmic mutations in tRNAArg, tRNAGlu, and tRNALeu(UUR) genes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne M Remes Research Topics

Disease

21	Alzheimer Disease (Alzheimer's Disease) 02/2022 - 04/2008
16	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2022 - 12/2008
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 02/2010
7	Frontotemporal Dementia (Semantic Dementia) 12/2021 - 01/2015
6	Atrophy 01/2022 - 01/2015
6	Dementia (Dementias) 04/2021 - 03/2009
5	Normal Pressure Hydrocephalus 02/2022 - 01/2015
5	Multiple Sclerosis 02/2022 - 01/2015
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 08/2004
4	Cognitive Dysfunction 01/2020 - 01/2013
3	Disease Progression 12/2021 - 01/2015
2	Mental Disorders (Mental Disorder) 12/2021 - 01/2020
2	Relapsing-Remitting Multiple Sclerosis 11/2021 - 02/2020
2	Neurobehavioral Manifestations 01/2020 - 01/2020
2	Bullous Pemphigoid (Pemphigoid) 01/2019 - 01/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 01/2018
2	Atherosclerosis 01/2018 - 01/2016
2	Genetic Risk Score 01/2017 - 01/2015
2	MELAS Syndrome (Syndrome, MELAS) 05/2008 - 08/2004
2	Hypoxia (Hypoxemia) 05/2008 - 02/2007
2	Neoplasms (Cancer) 05/2008 - 02/2007
1	Neuroinflammatory Diseases 02/2022
1	Gliosis 12/2021
1	Obstructive Sleep Apnea 01/2021
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2020
1	Parkinsonian Disorders (Parkinsonism) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Psychotic Disorders (Schizoaffective Disorder) 01/2020
1	Starvation 10/2019
1	Neuroblastoma 10/2019
1	Movement Disorders (Movement Disorder) 10/2019
1	Inflammation (Inflammations) 01/2019
1	Vascular Diseases (Vascular Disease) 01/2019
1	Schizophrenia (Dementia Praecox) 01/2017
1	Memory Disorders (Memory Loss) 12/2016
1	Optic Nerve Diseases (Optic Neuropathy) 02/2016
1	Ophthalmoplegia (External Ophthalmoplegia) 02/2016
1	Periodontitis 01/2016
1	Bone Resorption 01/2016
1	Periodontal Diseases (Periodontal Disease) 01/2016
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2015

Drug/Important Bio-Agent (IBA)

25	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2013
11	Amyloid (Amyloid Fibrils)IBA 02/2022 - 04/2008
7	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2012
5	Mitochondrial DNA (mtDNA)IBA 02/2016 - 08/2004
4	Immunoglobulin G (IgG)IBA 01/2019 - 03/2009
3	EnzymesIBA 01/2022 - 05/2008
3	Apolipoproteins E (ApoE)IBA 01/2019 - 09/2016
3	AutoantibodiesIBA 01/2019 - 01/2017
3	oxidized low density lipoproteinIBA 01/2018 - 03/2009
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022 - 01/2022
2	Tuberculin (PPD)IBA 12/2021 - 01/2020
2	Adenosine Triphosphate (ATP)IBA 11/2021 - 05/2008
2	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2021 - 10/2019
2	UbiquitinIBA 11/2021 - 10/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2004
2	Natalizumab (Tysabri)FDA Link 06/2020 - 02/2020
2	C-Reactive ProteinIBA 01/2020 - 01/2019
2	Peptides (Polypeptides)IBA 01/2019 - 01/2019
2	Lipoproteins (Lipoprotein)IBA 01/2019 - 03/2009
2	AntibodiesIBA 01/2018 - 03/2009
2	Immunoglobulin M (IgM)IBA 01/2018 - 01/2016
2	Apolipoprotein E4IBA 01/2017 - 12/2008
2	Arg Transfer RNAIBA 02/2016 - 08/2004
2	FumaratesIBA 05/2008 - 02/2007
1	Alemtuzumab (Campath)FDA Link 02/2022
1	Biological ProductsIBA 01/2022
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022
1	GranulinsIBA 01/2022
1	Glial Fibrillary Acidic ProteinIBA 11/2021
1	nitazoxanide (NTZ)FDA Link 02/2020
1	Chemokine CCL5IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Sirolimus (Rapamycin)FDA Link 10/2019
1	LipidsIBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	EpitopesIBA 01/2019
1	HDL CholesterolIBA 01/2019
1	HDL LipoproteinsIBA 01/2019
1	Phosphorylcholine (Phosphocholine)IBA 01/2018
1	Immunoglobulin A (IgA)IBA 01/2018
1	1,3,4,5,6-pentachlorocyclohexene-1-oxideIBA 01/2018
1	ApolipoproteinsIBA 01/2017
1	Antipsychotic Agents (Antipsychotics)IBA 01/2017
1	AutoantigensIBA 01/2017
1	Virulence Factors (Pathogenicity Factors)IBA 01/2016
1	Chaperonin 60IBA 01/2016
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2016
1	GadoliniumIBA 01/2015
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2015
1	Prealbumin (Transthyretin)IBA 01/2015
1	LDL Receptors (LDL Receptor)IBA 02/2014
1	CholesterolIBA 02/2014
1	lathosterolIBA 02/2014
1	Presenilin-2IBA 07/2012
1	Presenilin-1IBA 07/2012

Therapy/Procedure

4	Therapeutics 02/2022 - 01/2015
1	Activities of Daily Living (ADL) 01/2020
1	Drug Therapy (Chemotherapy) 01/2013